These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1710385)
61. Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety. Redmond DE; Huang YH Life Sci; 1979 Dec; 25(26):2149-62. PubMed ID: 120478 [No Abstract] [Full Text] [Related]
62. Current concepts. I. Anxiety: the locus coeruleus disconnection. Mason ST; Fibiger HC Life Sci; 1979 Dec; 25(26):2141-7. PubMed ID: 396433 [No Abstract] [Full Text] [Related]
63. Neurobiological mechanisms in human anxiety. Evidence supporting central noradrenergic hyperactivity. Charney DS; Redmond DE Neuropharmacology; 1983 Dec; 22(12B):1531-6. PubMed ID: 6142428 [TBL] [Abstract][Full Text] [Related]
64. Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B(12): mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems. Loder C; Allawi J; Horrobin DF Med Hypotheses; 2002 Nov; 59(5):594-602. PubMed ID: 12376086 [TBL] [Abstract][Full Text] [Related]
67. Myofascial pain disorders: theory to therapy. Wheeler AH Drugs; 2004; 64(1):45-62. PubMed ID: 14723558 [TBL] [Abstract][Full Text] [Related]
68. Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders. Wagstaff AJ; Bryson HM Drugs; 1997 Mar; 53(3):435-52. PubMed ID: 9074844 [TBL] [Abstract][Full Text] [Related]
69. Tizanidine and electrophysiologic analysis of spinal control mechanisms in humans with spasticity. Delwaide PJ; Pennisi G Neurology; 1994 Nov; 44(11 Suppl 9):S21-7; discussion S27-8. PubMed ID: 7970007 [TBL] [Abstract][Full Text] [Related]
70. Role of the locus coeruleus in the control of paradoxical sleep generation in the cat. Sakai K; Crochet S Arch Ital Biol; 2004 Jul; 142(4):421-7. PubMed ID: 15493546 [No Abstract] [Full Text] [Related]
71. Spinal and locus coeruleus noradrenergic lesions abolish the analgesic effects of 5-methoxy-N,N-dimethyltryptamine. Danysz W; Jonsson G; Minor BG; Post C; Archer T Behav Neural Biol; 1986 Jul; 46(1):71-86. PubMed ID: 3015120 [TBL] [Abstract][Full Text] [Related]
72. Noradrenergic mechanisms involved in muscle relaxation: significance for the treatment of spasticity. Wiesendanger M; Corboz M; Palmeri A; Chen DF; Palmer CI Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):132-4. PubMed ID: 1710385 [No Abstract] [Full Text] [Related]
73. Spasticity: a review. Young RR Neurology; 1994 Nov; 44(11 Suppl 9):S12-20. PubMed ID: 7970006 [TBL] [Abstract][Full Text] [Related]